GERN Q3 2022 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$297,000+172.5% YoY

Gross Profit

-$24M-8183.8% margin

Operating Income

-$40M-13450.5% margin

Net Income

-$41M-13821.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+306.8%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$233M

Total Liabilities

$124M

Stockholders' Equity

$108M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$297,000	$109,000	+172.5%
Gross Profit	-$24M	-$18M	-32.0%
Operating Income	-$40M	-$26M	-55.6%
Net Income	-$41M	-$27M	-53.8%